Veeco Ship 200th TurboDisc MOCVD System

Veeco Instruments Inc. (Nasdaq: VECO), announced today that it has shipped its 200thTurboDisc(R) K465i(TM) Metal Organic Chemical Vapor Deposition (MOCVD) System to a leading LED manufacturer located in Asia.

"We are pleased that since its introduction to the market in January 2010, the K465i has become the market leading MOCVD system for high volume manufacturing of LEDs," said Bill Miller, Ph.D., Executive Vice President, Compound Semiconductor and head of Veeco's MOCVD Operations. "We are proud of Veeco's ability to ramp production of the K465i and support our global customers to meet the strong demand for tools as LED adoption accelerates for backlighting and lighting applications. This is a significant milestone for our business."

The production-proven K465i extends Veeco's lead in capital efficiency - the number of good wafers per day for each capital dollar - for high volume LED manufacturers. The K465i provides ease-of-tuning for fast process optimization on wafer sizes up to 8 inches and fast tool recovery time after maintenance.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Veeco. (2019, February 10). Veeco Ship 200th TurboDisc MOCVD System. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=26573.

  • MLA

    Veeco. "Veeco Ship 200th TurboDisc MOCVD System". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=26573>.

  • Chicago

    Veeco. "Veeco Ship 200th TurboDisc MOCVD System". AZoM. https://www.azom.com/news.aspx?newsID=26573. (accessed November 23, 2024).

  • Harvard

    Veeco. 2019. Veeco Ship 200th TurboDisc MOCVD System. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=26573.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.